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Abstract 
The effects of elementary metallic nanoparticles on living objects as cytotoxicity or antibacterial activity are widely 
known. Ag nanoparticles are a suitable and well known example. Nanoparticles formed by an alloy of Ag and Cu 
stabilized by polyvinyl alcohol were examined on two human tumor cells - ovarian carcinoma cells A2780 and skin 
melanoma cells A375. Bimetallic AgCu nanoparticles were synthesized by using a method of chemical co-reduction of 
silver nitrate and copper (II) nitrate hydrate. The nanoparticles were characterized by electron microscopy and by 
measurement of zeta potential. Cell viability was tested by using an MTT (tetrazole colorimetric viability assay) test. 
The effect on cell apoptosis and necrosis was measured by using flow cytometry. The experimental results indicate 
a differentiated impact of nanoparticles on the cells used. A more significant effect of viability decrease was observed 
for A2780 cells. The cell death caused by the nanoparticles used was observed particularly in the form of initial and 
advanced apoptosis for both cells lines, necrosis was observed to a lesser extent. The synthesized bimetallic 
nanoparticles seem to be a suitable candidate for targeted suppression of cell proliferation. 
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Introduction  
The amount of metallic nanoparticles (NPs) in the 
environment and in everyday consumer products is 
increasing rapidly. NPs are included, for example, in 
cosmetics, clothing, personal care products, and even 
many foods items [1]. For this reason, there are 
legitimate concerns about the possible interaction 
between NPs and living tissues. The toxicity of some 
of the particles was demonstrated in both lower and 
higher organisms [2–4]. Silver, copper or titanium 
oxide NPs are among the frequently mentioned NPs 
exhibiting cell toxicity and an antifungal/antibacterial 
effect, for example [5–7]. It is logical that NPs, mainly 
metallic, are considered to be one of the most 
promising agents for cancer therapy. They have been 
discovered to be drug carriers, photothermal agents, 
contrast agents, radiosensitisers or they have direct 
effect on cells viability [8, 9]. 
These biological properties of NPs can be observed 
because of their extremely small dimensions as well as 
their shape, crystalline structure, composition, and 
surface structure. 
Bimetallic NPs are also increasingly synthesized, but 
still not to such a great extent as monometallic NPs. 
Bimetallic NPs represent combinations of various 
metallic materials formed into objects at sizes below 
100 nm. One of the possible combinations of metallic 
materials is silver and copper, formed into AgCu NPs 
with various surface modifications [10]. AgCu nano-
materials find application in chemistry as a catalyst 
[11] or in electrochemistry [12]. AgCu NPs find 
applications in medicine too. The addition of AgCu 
NPs improves corrosion resistance of amalgam compo-
sition in dentistry [13]. AgCu bimetallic particles 
exhibit toxicity and a manifest antibacterial effect [14], 
which is even much higher than the effect of Ag NPs 
alone [15]. Despite all these facts, AgCu NPs are not 
often presented and described in biomedical appli-
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cations. We assume that the research area of AgCu NPs 
is still open in this respect. 
The aim of this study was to design, produce and test 
bimetallic AgCu NPs with the purpose to affect tumor 
cell viability. The structure of NPs and types of 
metallic materials were chosen based on the individual 
characteristics and effects of the Ag and Cu. As already 
mentioned, AgCu NPs composites have better anti-
microbial properties compared to the Ag or Cu NPs 
alone [14]. There was an effort to shift the research of 
NPs’ effects from the antibacterial to the cytotoxic 
level. Tested AgCu NPs were modified by polyvinyl 
alcohol (PVA), which ensures their shape and size 
stability in time without aggregation – the stability of 
NPs was observed over a time period of more than 
three months after synthesis. The PVA surfactant used 
was selected after previous tests with other surfactants. 
All other tested surfactants showed more significant 
toxic properties compared to PVA on carcinoma cells 
[16]. The use of PVA as a stabilization component of 
NPs is known, especially in connection with Ag NPs 
[17, 18], but the reported toxicity was tested just on the 
bacterial level. The aim of the present study was to 
clarify effect on tumor cells in vitro. 
Materials and methods  
Cell cultures and chemicals 
Human ovarian carcinoma cell line A2780 and 
human skin melanoma cell line A375 were used, 
obtained from the European Cell Culture Collection. 
Roswell Park Memorial Institute medium (RPMI 
medium - 1640) with L-glutamine (Bio Tech, Ltd., 
Prague, Czech Republic) supplemented with 10% fetal 
calf serum (Bio Tech, Prague, Czech Republic) and 
100 μg∙ml-1 streptomycin/penicillin (Bio Tech, Prague, 
Czech Republic) was used. The cell line was grown in 
cell culture flasks in an atmosphere of 95% air and 5% 
CO2 at 37 °C. The cells were detached from the glass 
by trypsin addition (Bio Tech, Prague, Czech 
Republic). 
AgCu nanoparticle 
The samples of the AgCu nanoalloy colloids were 
synthesized by chemical co-reduction of silver nitrate 
and copper (II) nitrate hydrate as precursors and with 
polyvinyl alcohol (PVA) as a surfactant and sodium 
borohydride as reducing agent in methanol p.a. at 
40 °C under a nitrogen atmosphere. The metal pre-
cursor amounts were equivalent to a particular stoi-
chiometric ratio Ag – 28.1 wt% Cu in a eutectic alloy. 
Synthesized nanoparticles were separated by centri-
fugation for 10 min at 6000 rpm. The nanoparticles 
were washed to remove organic-soluble residues by 
three or more cycles of resuspending in deionized 
Millipore water. The Ag and Cu metal content was 
analyzed by inductively-coupled plasma optical emis-
sion spectroscopy (ICP-OES, iCAP 6500 Duo Thermo, 
UK) calibrated on Ag and Cu pure metals. The hydro-
dynamic size of AgCu NPs in the colloidal state was 
measured by the dynamic light scattering (DLS) 
method on a Zetasizer Nano ZS ZEN 3500 instrument 
(Malvern Instruments, UK) [19]. Zeta potential was 
also measured by DIP-cell on the same instrument. The 
metal cores of the AgCu NPs were investigated by 
transmission electron microscopy (TEM) because this 
technique is insensitive to elements of the organic 
shell. The size and shape of AgCu NP cores were 
investigated using a CM12 STEM microscope 
(Philips). 
Viability test 
The following procedure was used to compare the 
viability of cells A2780 and A375 incubated with 
AgCu NPs with a control group of cells: a cell’s 
suspension was obtained by trypsinization of cells 
adhering to the flask bottom. To the well of a 96-well 
plate containing cells in concentration of 5∙104 ml-1 in 
RPMI medium, a calculated volume of AgCu NPs 
stock solution was added to achieve a final con-
centration of nanoparticles of 1, 2, 4, 6, 8, 10 and 
50 mg∙l-1. An equal volume of phosphate-buffered 
saline (PBS) free of NPs was added to the control cells. 
No trypsin was added. After incubation for 48 hours, 
the cells were washed in PBS and evaluated by 
a standard mitochondrial MTT test of viability [20]. 
Using an EL800 microplate reader (Bio-Tek, USA) the 
absorbance of a color product in each well was 
recorded at 570 nm. The absorbance value for NPs 
alone was subtracted from all corresponding cells’ 
samples. The amount of the color product is directly 
proportional to the metabolic activity of mitochondria 
(i.e., viability) in living cells. 
The action of PVA alone was also tested. The 
solution of PVA in concentration equal to the concen-
tration of PVA in samples of NPs of concentration 
5 mg∙l-1 and 50 mg∙l-1 was added into a cell suspension 
of the 5∙104 cell in RPMI medium and seated on 96-
well plate. The incubation time was 48 hours. The 
viability was tested by using an MTT test. The 
absorbance value was recorded at 570 nm. 
Flow-cytometric analyses 
The early apoptosis, late apoptosis, necrosis and 
normal cell population were detected by using Annexin 
V- Dyomics 647 (Exbio, Czech Republic) and 
Propidium Iodide (PI) (Sigma Aldrich, USA). The 
measurements were carried out on the unaffected cells 
control sample and on cells incubated with NPs of 
concentration 5 mg∙l-1 (close to IC50 - the half 
maximal inhibitory concentration) at a time of 48 
hours. The labeling process was as follows: cells were 
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washed with PBS, centrifugated at 1000 rpm, fixed by 
500 μl Annexin V Binding Buffer (Exbio, Czech 
Republic) per sample and stained with 5 μl Annexin V 
Dyomics 647 per sample for 30 min on ice and 5 μl PI 
per sample. The amount of cells per one sample of 
flow-cytometric analysis was 1∙106. 
Samples were acquired using a Navios flow 
cytometer (10 colors, 3 lasers) (Beckman Coulter, 
USA) and cytometry data (LMD files) were analyzed 
with Kaluza software (Beckman Coulter, Inc, USA). 
Statistical analysis 
The absorbance value for each sample was converted 
into cell viability as follows: the median absorbance 
value of the control group “contr” was taken as 100%; 
the absorbance of each other sample was expressed as 
a percentage of the control value, i.e., its viability 
relative to that of the control sample. Because of a non-
normal distribution of the values for individual groups, 
the non-parametric Mann-Whitney t-test at a signifi-
cance level of p = 0.05 was used. Samples with 
corresponding concentration of NPs were compared 
with each other. The statistical software STATISTICA 
12 (StatSoft, Inc., USA) was used to calculate the 
median and the upper and lower quartiles. 
The data of viability of each experimental sample 
shown in box-plot graphs were obtained from 
8 different analyses. 
Results  
NPs characteristic 
The size and shape of AgCu NPs colloids were 
observed by TEM. The TEM images obtained showed 
nanoparticles of size below 100 nm, as is documented 
in Figure 1. Observed nanoparticles have a regular 
spherical shape, without major shape deviations. 
 
 
 
Fig. 1: TEM image of nanoparticles of AgCu/PVA. 
 
The average diameter of NPs obtained by using the 
DLS method was 64.04±9.6 nm. The percentage of 
individual components of NPs was also measured 
overall composition of the sample was 64.5 wt% for 
Ag and 35.5 wt% for Cu. The mass of the organic layer 
of PVA of the dried nanoparticles was about 90%. 
Nanoparticles alone represented only 10% of the mass. 
Zeta potential measured for AgCu NPs with an organic 
layer formed by PVA was -16.4 mV. The results from 
basic characterization of AgCu NPs are shown in Table 
1. 
 
Table 1: Experimental characterization of AgCu NPs. 
Parameter Experimental value 
Composition (Ag/Cu) (wt%) 64.50/35.50 
Av. diameter by DLS (nm) 64.04 
Av. diameter by TEM (nm) 16/23 (bimodal) 
 Zeta potential (mV) -16.4 
Viability test 
The effect of AgCu NPs and PVA alone on viability 
of cells A2780 and A375 were tested. The viability 
values of cells in the experimental samples with 
different final concentrations of NPs (1, 2, 4, 6, 8, 10 
and 50 mg∙l-1) were compared with the value of the 
control group (contr). The results of this testing for 
both cell lines used (A2780 and A375) are presented in 
Figure 2. The presented box-plots graphs show that the 
effect of AgCu on cell viability is different for different 
cell lines. A more significant effect was observed for 
ovarian carcinoma cell lines A2780 compared with 
melanoma skin cells A375. The IC50 value for A2780 
cells was defined as 6–6.5 mg∙l-1 in comparison to IC50 
values for A375 cells in a range of 35–40 mg∙l-1 (with 
regard to the variance of data). It is evident that for 
a similar viability effect it is necessary to increase the 
concentration of NPs for skin melanoma cells. The 
significant differences between A2780 and A375 cell 
viability were not observed for lower concentrations of 
NPs; significant differences were found at concen-
trations higher than 4 mg∙l-1 for all used cells (Table 2). 
 
Table 2: Significance of differences in viability values, 
as assessed by the Mann-Whitney test. 
A2780  A375 
contr + contr 
1 mg∙l-1 * 1 mg∙l-1 
2 mg∙l-1 + 2 mg∙l-1 
4 mg∙l-1 + 4 mg∙l-1 
6 mg∙l-1 * 6 mg∙l-1 
8 mg∙l-1 * 8 mg∙l-1 
10 mg∙l-1 * 10 mg∙l-1 
Symbols: * statistical significance at level p < 0.05, 
+ no statistical significance at level p < 0.05 
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We made an attempt to determine the influence of 
PVA on decreases in cell viability. The PVA alone was 
tested using both cell lines. PVA was applied in 
a concentration equal to the concentration of PVA in 
NPs samples of concentration of 5 mg∙l-1 and 50 mg∙l-1. 
The results show only a relatively weak influence of 
this surfactant on cell viability in comparison of effect 
of NPs. A decrease of cells’ viability to the value of 
76% was observed for concentrations of 50 mg∙l-1 for 
cell line A2780 and 90% in case of cell line A375 
(Figure 3). 
 
 
Fig. 2: Cell viability at 48 h of incubation with AgCu 
NPs modified by PVA. Samples: contr – control 
sample, 1 – AgCu NPs in concentration 1 mg·l-1, 2 – 
AgCu NPs in concentration 2 mg·l-1, 4 – AgCu NPs in 
concentration 4 mg·l -1, 6 – AgCu NPs in concentration 
6 mg·l-1, 8 – AgCu NPs in concentration 8 mg·l-1, 10 – 
AgCu NPs in concentration 10 mg·l-1, 50 – AgCu NPs 
in concentration 50 mg·l-1. 
 
 
Fig. 3: Cell viability at 48 h of incubation with PVA 
alone. Samples: contr – control sample, 5 – PVA in 
concentration equal to concentration of PVA in sample 
of NPs of 5 mg·l-1, 50 – PVA in concentration equal to 
concentration of PVA in sample of NPs of 50 mg·l-1. 
Flow-cytometric analyses 
Flow-cytometric analyses were carried out in order 
to determine the state of the cell suspension after 
exposure to NPs. The percentage of normal cells, early 
apoptotic cells, late apoptotic cells and necrotic cells 
was measured. The results obtained showed differences 
in effects of NP samples for both cell lines in 
comparison with control (Figure 4). A large number of 
cells was observed in the stage of apoptosis, 78.5% 
(59.0% when control was subtracted) for cell line 
A2780 and 83.2% (79.4% when control was sub-
tracted) for cell line A375. The amounts of necrotic 
cells were observed as 1.7% for A375 cells compared 
to a value of 0.2% for cell line A2780. 
 
 
Fig. 4: Flowcytometry analyses: The quadrants for all 
graphs represent: top left - late apoptosis, top right - 
early apoptosis, down left - normal cell population and 
down right - necrosis. Image A represents the control 
sample of the A2780 cell line, image B shows an NP 
sample of the A2780 cell line, image C shows a control 
sample of the A375 cell line and image D shows an NP 
sample of the A375 cell line. 
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Discussion  
We used two different types of tumor cells lines, 
ovarian carcinoma cells A2780 and skin melanoma 
cells A375. It is substantiated by different sensitivity of 
various cell lines to applied nanoparticles generally 
[21]. This phenomenon was observed in our study as 
well. 
It is clear from the data obtained that the synthesized 
AgCu/PVA NPs exhibited an ability to reduce cell 
viability. The toxicity of NPs was higher for the 
ovarian carcinoma cell line A2780 in comparison 
with A375 cells, as was documented by using MTT 
testing of cell viability. Based on the use of PVA 
without NPs (control groups), we can say that the 
major effect is conditioned by the presence of NPs. 
The IC50 value for A2780 cells was measured in 
a range of 6–6.5 mg∙l-1, IC50 value for A375 cells was 
35–40 mg∙l-1. We can compare the observed IC50 dose 
of AgCu NPs with results of other authors (obtained by 
MTT test, only for pure Ag and Cu NPs). The silver 
dose for IC50 was documented as 19.33 mg∙l-1 for 
THP-I cells [4] or by other authors as 35.6 mg∙l-1 for 
HaCaT cells [22]. The lower concentrations were 
observed for commercial Ag NPs [21], where the IC50 
were 2.7 mg∙l-1 for SVK14 cells, and 1.9 mg∙l-1 for 
NIH3T3 cells. The IC50 was 15 mg∙l-1 for Cu NPs, and 
50 mg∙l-1 for CuO NPs [23]. The various sizes of NPs 
were used in all the studies. It is also one of the factors 
determining the final toxicity effect. The effect of 
newly synthesized AgCu/PVA NPs seems to be 
adequate to other results of other authors. The 
beneficial long stability was reached thanks to PVA 
modification. 
The value of Zeta potential of studied AgCu NPs can 
be compared with other authors. The AgCu NPs 
stabilized by sapota and latex of DLS size 40 nm 
showed Zeta value of -15.24 mV [24]. In this case, the 
size and namely Zeta potential are almost the same. 
The same authors show the AgCu NPs with DLS size 
25 nm, where the Zeta potential was -10.22 nm. The 
paper from Patra and Dasgupta commented that neither 
size nor zeta potential alone determine the optimal 
cellular response induced by NPs [25], but the effect of 
charge of NPs on affinity to cells was documented 
[26]. 
The observed main type of cell death for both cell 
lines after being affected by AgCu/PVa was apoptosis. 
This result is consistent with the observation of the 
previous study on Ag NPs [21]. However, this is in 
contrast with some other studies with Cu or CuO NPs 
that show a higher incidence of necrosis [23]. The 
mechanism leading to apoptosis death can be multiple, 
with Reactive oxygen species being one of the 
intermediate steps in this action. Other described 
factors caused by NPs are DNA damage, membrane 
leakage, and inhibition of mitochondria function, 
membrane lipid peroxidation, decreasing of actin 
cytoskeletal integrity or by release of metallic ions in 
aqueous state [27]. It is obvious that the mechanism of 
cell death depends not only on the type of nanoparticles 
used but on the cell line too. The main cause of 
a difference in the effect of NPs is found mainly as the 
influence of cell phenotype, growth rate, metabolic 
rate, different ability of phagocytosis, difference in 
transmembrane protein [28]. 
Conclusion  
The results of our experiments show the possibility 
of synthesis of AgCu NPs and their surface 
modification by PVA. The experiments presented 
showed the relatively long-lasting stability and toxicity 
of nanoparticles determined by a selected type of metal 
composition on carcinoma cells. The experiments 
didn´t show considerable toxicity of PVA alone. It was 
found that the decrease of cell viability caused by 
presence of nanoparticles depended also on the used 
type of carcinoma cells. The maximal effect on 
viability was observed for the ovarian carcinoma cell 
line. The mechanism of cell death for both cells lines 
was determined as apoptosis. According to the results 
obtained, the synthesized nanoparticles may be 
applicable in the treatment of tumors, not just as an 
antibacterial agent which is relatively well known. 
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